He would never tell you, partly because he was so modest, but mainly because he didn’t really understand it himself. But ...

Biogen has announced a definitive agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion, a move that would expand its presence in complement-mediated diseases, including ...

The Rust patch notes are here for the Spring Clean update, with a new Armored Ladder Hatch, a Water Wheel, a shield nerf, and ...

The dream of deploying humanoid robots in every home has created a new type of job. The only requirements are a head strap, a ...

The US Food and Drug Administration has approved the extension of dosing intervals for Regeneron’s EYLEA HD (aflibercept) up ...

In an 8-1 decision authored by Justice Neil Gorsuch, the Supreme Court held on March 31, 2026, that a Colorado law ...

The incident led to questions about how such a grave mistake took place. Any type of procurement in government hospitals is ...

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements ...

By 85, according to the Social Security Administration, it’s more like 10 percent. Death comes quickly.) Soon after the carry ...

Biogen acquires Apellis Pharmaceuticals in a deal that brings two marketed complement therapies into its portfolio, ...